Mesoblast
MESO
#4508
Rank
ยฃ1.67 B
Marketcap
ยฃ12.65
Share price
0.87%
Change (1 day)
-21.58%
Change (1 year)

Operating Margin for Mesoblast (MESO)

Operating Margin at the end of 2025: -592.00%

According to Mesoblast 's latest financial reports and stock price the company's current Operating Margin is -591.99%. At the end of 2025 the company had an Operating Margin of -592.00%.

Operating Margin history for Mesoblast from 2005 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2025-592.00%-60.36%
2024-1,493.51%36.45%
2023-1,094.53%22.03%
2022-896.93%-33.07%
2021-1,340.19%385.02%
2020-276.32%-53.21%
2019-590.56%51.94%
2018-388.67%-91.62%
2017-4,640.69%2018.95%
2016-219.01%-55.03%
2015-487.04%50.83%
2014-322.92%54.72%
2013-208.71%63.44%
2012-127.70%-267.33%
201176.32%-103.95%
2010-1,932.36%-70.7%
2009-6,594.63%496.26%
2008-1,105.99%112.8%
2007-519.74%76.73%
2006-294.09%0.58%
2005-292.39%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Nymox Pharmaceutical
NYMX
-234,760.00% 39,556.08% Bahamas
NRC Health
NRC
22.85%-103.86%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.